#None #Menopause #Ayurveda #Menoveda

Spotlight on Menopause Management with Menoveda

As the global conversation around women's health continues to evolve, the significant challenges posed by menopause have begun to attract much-needed attention. At the recent Menopause Society 2025 Annual Meeting in October, new research has shed light on alarming trends regarding menopause and women's health, brought forth by Menoveda—a pioneering female health and wellness brand.

The insights revealed key statistics suggesting an urgent call for proactive strategies and educational resources regarding menopause. Menoveda has identified three pivotal health risks associated with menopause that require immediate focus:

1. Impact on Brain and Cardiac Health: The data suggests that women entering menopause early face increased risks related to brain aging and overall cardiac function, elevating their vulnerability to conditions such as dementia. This revelation raises awareness about the potential long-term neurological impacts that menopause can have on women, particularly those with early onset.

2. Metabolic Syndrome Concerns: Women who experience early menopause may have a staggering 27% heightened risk of developing metabolic syndrome—a condition linked to significant health issues including cardiovascular disease and type 2 diabetes. Understanding this risk is crucial especially for women who may be unaware of these alarming health intersections.

3. Undiagnosed Digestive Health Issues: The lack of proper recognition and support for menopausal women has resulted in many experiencing digestive health problems without appropriate diagnosis. This gap in care underscores the critical need for healthcare providers to better address the diverse health challenges faced by women going through menopause.

Mrs. Tamanna Singh, the founder of Menoveda, highlighted the global neglect surrounding the topic of menopause in her statement: “Menopause remains a neglected conversation globally, particularly affecting women of color, who often experience early and misunderstood symptoms.” In the U.S. alone, tens of millions of women are managing menopause, frequently without adequate support.

Menoveda is taking significant strides toward altering this landscape. With scientifically-backed Ayurvedic formulations designed with modern women in mind, they not only address these pressing health issues but also bring a holistic approach to women's wellness that honors traditional practices. The company, born from Singh's own journey with perimenopause, has fostered a team of experts, including doctors and Ayurvedacharyas, to provide comprehensive support to women navigating the menopausal transition.

Menoveda's unique formulations are crafted with deep respect for ancient wisdom and contemporary scientific standards, merging Ayurveda's 5,000-year legacy of wellness with modern clinical rigor. Their approach results in dietary supplements that are safe, effective, and adaptable to the needs of today’s women.

As research emphasizes the necessity for enhanced awareness and educational initiatives, Singh has created a female-forward ecosystem that prioritizes comprehensive care throughout the menopause journey. Recognizing that Menoveda stands among a select few brands providing end-to-end holistic care in this field, it also plays an integral role in shifting the health dialogue about menopause to the forefront of global health discussions.

In conclusion, Menoveda LifeSciences, founded in 2022 in Delhi by Tamanna Singh and her husband, Gautam Singh, encapsulates a progressive approach to menopause wellness, intertwining traditional Indian Ayurvedic principles with scientific knowledge and support—elevating the narrative and care surrounding menopause not just in India, but across the globe.

For more information, visit Menoveda's website.